Cargando…

The Severity of Depressive Symptoms vs. Serum Mg and Zn Levels in Postmenopausal Women

The aim of this study was to assess the severity of depressive symptoms in postmenopausal women, depending on serum Mg and Zn levels. The study involved 171 postmenopausal women from Poland, who were not using menopausal hormone therapy (MHT). The intensity of depressive symptoms was evaluated using...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanisławska, M., Szkup-Jabłońska, M., Jurczak, A., Wieder-Huszla, S., Samochowiec, A., Jasiewicz, A., Noceń, I., Augustyniuk, K., Brodowska, A., Karakiewicz, B., Chlubek, D., Grochans, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895221/
https://www.ncbi.nlm.nih.gov/pubmed/24271492
http://dx.doi.org/10.1007/s12011-013-9866-6
Descripción
Sumario:The aim of this study was to assess the severity of depressive symptoms in postmenopausal women, depending on serum Mg and Zn levels. The study involved 171 postmenopausal women from Poland, who were not using menopausal hormone therapy (MHT). The intensity of depressive symptoms was evaluated using a standard research technique, the Beck Depression Inventory (BDI). The plasma Mg and Zn concentrations were measured. Depressive symptoms of different severity levels were diagnosed in 36.8 % of the women. The mean serum Mg level was 1.53 ± 0.28 mg/dL, and Zn level was 72 ±14 μg/dL. The women with higher serum Mg and Zn levels had less depressive symptoms, and this observation is a precious information which can be used when planning depressive disorder prevention programmes.